The Landmark RCT - One-year results
Sponsored by Meril
TAVI
Symposium
Meril Life
Theatre Bordeaux
Anchorperson: Patrick Serruys
Spokesperson: Andreas Baumbach
Discussants: Francesco Bedogni, Fausto Feres, Markus Kasel, Julia Mascherbauer, Andreas Rück, Giuseppe Tarantini
Guest speakers: Ignacio J Amat-Santos, Matjaz Bunc, Yoshinobu Onuma, Pieter Smits, Niels Van Royen
Watch this session if you want
- To gain deep understanding of VARC-3 recommendations on TAVI trials
- To better understand the LANDMARK trial results: one-year follow-up
- To learn about one-year results in specific cohorts - Women, small annuli, pacemaker dependency in patients with new PPI
Welcome and session objectives
Patrick Serruys
First ever analysis of TAVI trial based on VARC-3- deep understanding of the basic principle of analysis
Yoshinobu Onuma
One-year outcomes of LANDMARK trial
Patrick Serruys
Discussion and audience interaction
Detailed analysis of primary endpoint (clinical efficacy)
Andreas Baumbach
Hemodynamic analysis
Matjaz Bunc
One-year pacemaker dependency in PPI patients
Pieter Smits
Discussion and audience interaction
Outcomes from the LANDMARK trial: women sub-set
Ignacio J Amat-Santos
30-day outcomes from the LANDMARK trial: small annuli patients
Niels Van Royen
Discussion and audience interaction
Session evaluation and key learnings
Andreas Baumbach
